JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells

Dharminder Chauhan1, Guilan Li, Teru Hideshima

  • 1Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.

Insights

The c-Jun NH(2)-terminal kinase (JNK) pathway is crucial for releasing Smac (second mitochondria-derived activator of caspases) from mitochondria during apoptosis in multiple myeloma cells, initiating programmed cell death.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Smac (second mitochondria-derived activator of caspases) is a key protein promoting apoptosis by activating caspases.
  • The role of c-Jun NH(2)-terminal kinase (JNK) in Smac release during apoptosis remains unclear.
  • Previous research links JNK to cytochrome c regulation in apoptosis.

Purpose of the Study:

  • To investigate the role of JNK in the mitochondrial release of Smac during apoptosis in multiple myeloma (MM) cells.
  • To determine if JNK activation is necessary for Smac release and subsequent apoptosis induction.

Main Methods:

  • Induction of apoptosis in multiple myeloma cells.
  • Analysis of JNK activation and translocation.
  • Assessment of Smac release from mitochondria.
  • Inhibition of JNK using a dominant-negative mutant (DN-JNK) and a specific inhibitor (SP600125).

Main Results:

  • Apoptosis induction in MM cells correlated with JNK activation and its translocation to mitochondria.
  • JNK translocation preceded the release of Smac from mitochondria to the cytosol.
  • Inhibition of JNK signaling abrogated both Smac release and apoptosis.
  • Blocking JNK prevented stress-induced Smac release and apoptosis.

Conclusions:

  • JNK activation is an essential event for Smac release during stress-induced apoptosis in multiple myeloma cells.
  • JNK signaling pathway plays a critical role in regulating mitochondrial Smac release, a key step in apoptosis.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...